These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10841318)

  • 1. Thiorphan, an inhibitor of neutral endopeptidase/enkephalinase (CD10/CALLA) enhances cell proliferation in bone marrow cultures of patients with acute leukemia in remission.
    Stanović S; Boranić M; Petrovecki M; Batinić D; Skodlar J; Nemet D; Labar B
    Haematologia (Budap); 2000; 30(1):1-10. PubMed ID: 10841318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiorphan stimulates clonal growth of GM-CFU in short-term cultures of bone marrow from a healthy donor and from patients with non-Hodgkin lymphoma.
    Stanović S; Boranić M; Petrovecki M; Nemet D; Skodlar J; Golubić-Cepulić B; Batinić D; Labar B
    Biomed Pharmacother; 1998; 52(9):397-402. PubMed ID: 9856287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a membrane-metallopeptidase blocking agent thiorphan in long-term cultures of human bone marrow.
    Stanović Janda S; Boranić M; Sucić M; Petrovecki M; Golubić-Cepulić B; Aurer I; Labar B
    Haematologia (Budap); 2000; 30(4):289-302. PubMed ID: 11204028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enkephalinase-blocking agent thiorphan affects cell growth and differentiation in long term culture of mouse bone marrow.
    Krizanac-Bengez L; Boranic M
    Biomed Pharmacother; 1995; 49(7-8):375-80. PubMed ID: 8562866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines.
    Batova A; Shao LE; Diccianni MB; Yu AL; Tanaka T; Rephaeli A; Nudelman A; Yu J
    Blood; 2002 Nov; 100(9):3319-24. PubMed ID: 12384433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of enkephalinase (EC 3.4.24.11) activity on various leukemic cells expressing the common acute lymphocytic leukemia antigen (CALLA).
    Arock M; Gros C; Devillier P; Guillosson JJ; Schwartz JC
    FEBS Lett; 1989 May; 248(1-2):123-6. PubMed ID: 2524403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy.
    van Lochem EG; Wiegers YM; van den Beemd R; Hählen K; van Dongen JJ; Hooijkaas H
    Leukemia; 2000 Apr; 14(4):688-95. PubMed ID: 10764156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of recombinant human stem cell factor on mafosfamide-treated bone marrow clonogenic cells.
    Carlo-Stella C; Mangoni L; Almici C; Caramatti C; Rizzoli V
    Stem Cells; 1993 Jul; 11 Suppl 2():170-4. PubMed ID: 7691323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
    Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
    Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S; Bhalla K; Arlin Z; Howe CW
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration of functional CD40 in B-lineage acute lymphoblastic leukemia cells in response to T-cell CD40 ligand.
    Renard N; Lafage-Pochitaloff M; Durand I; Duvert V; Coignet L; Banchereau J; Saeland S
    Blood; 1996 Jun; 87(12):5162-70. PubMed ID: 8652829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methionine enkephalin suppresses metabolic activity of a leukemic cell line (NALM-1) and enhances CD10 expression.
    Martin-Kleiner I; Gabrilovac J; Kusec R; Boranić M
    Int Immunopharmacol; 2003 May; 3(5):707-11. PubMed ID: 12757739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors.
    Plasilova M; Zivny J; Jelinek J; Neuwirtova R; Cermak J; Necas E; Andera L; Stopka T
    Leukemia; 2002 Jan; 16(1):67-73. PubMed ID: 11840265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal in vitro differentiation of clonogenic B-cells in common acute lymphoblastic leukemia in complete remission. A marker for minimal residual disease?
    Bréard J; Mathé G; Consolini R
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():47-50. PubMed ID: 2977810
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of myelopoietic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia.
    Benko I; Kovács P; Szegedi I; Megyeri A; Kiss A; Balogh E; Oláh E; Kappelmayer J; Kiss C
    Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):499-508. PubMed ID: 11383710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lithium chloride on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic leukaemic blasts (CFU-L) in the cultures in vitro.
    Korycka A; Robak T
    Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):495-500. PubMed ID: 1668709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal in vitro differentiation of clonogenic B-cells in common acute lymphoblastic leukemia in complete remission. A marker for minimal residual disease?
    Bréard J; Mathé G; Consolini R
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):47-50. PubMed ID: 2525967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.